Oaktree Specialty Lending prices $300 million of 7.000% notes due 2031

Oaktree Specialty Lending Corporation entered into an underwriting agreement on September 9 for the issuance and sale of $300.0 million aggregate principal amount of its 7.000% Notes due 2031. The company disclosed the agreement in a Form 8-K filed September 11. Closing is expected September 16, 2026, subject to customary closing conditions. The filing identifies OCSL as the trading symbol for the company's common stock on Nasdaq (Form 8-K AccNo 0001193125-26-389266).

CONTEXT: The financing is at the pricing and signed-underwriting-agreement stage

The financing is at the pricing and signed-underwriting-agreement stage described in the disclosure. That is distinct from a completed closing: the expected September 16 date remains conditional. The disclosed transaction should therefore be read as an agreed offering with an anticipated settlement milestone, rather than evidence that the company has already received the proceeds. Neither the agreement date nor the filing date makes this a new Sunday overnight announcement.

FACT: The company said net proceeds will be $296

The company said net proceeds will be $296.5 million after deducting an underwriting discount of $2.6 million and estimated offering expenses of approximately $800,000, both payable by the company. Those are the amounts disclosed in Item 1.01. The $300.0 million headline amount describes the aggregate principal of the notes; the $296.5 million figure describes the company's disclosed net proceeds after offering deductions.

CONTEXT: Keeping those figures separate matters when assessing the financing

Keeping those figures separate matters when assessing the financing. Principal measures the stated amount of notes being issued, while net proceeds describe the amount the company expects after the disclosed deductions. The filing presents the underwriting discount and estimated expenses separately, and the expense estimate is approximate. Readers should retain the company's disclosed $296.5 million net figure rather than substitute an independently reconstructed total from the rounded deduction figures.

FACT: The underwriting agreement includes Oaktree Specialty Lending, Oaktree F

The underwriting agreement includes Oaktree Specialty Lending, Oaktree Fund Advisors, LLC and Oaktree Fund Administration, LLC. J.P. Morgan Securities LLC, BNP Paribas Securities Corp., ING Financial Markets LLC, RBC Capital Markets, LLC and SMBC Nikko Securities America, Inc. are named as representatives of the several underwriters. Item 9.01 lists the September 9 underwriting agreement as Exhibit 1.1 to the filing.

FACT: The offering is being made under the company's effective shelf registrat

The offering is being made under the company's effective shelf registration statement on Form N-2, Registration No. 333-292920. The filing says that registration statement was supplemented by a preliminary prospectus supplement dated September 9 and a final prospectus supplement bearing the same date. These references identify the registration and prospectus framework stated in the 8-K for this particular notes offering.

UNKNOWN: Item 1

Item 1.01 does not state how the company will use the proceeds or give the issue price as a percentage of principal. It also does not provide credit ratings or the additional indenture mechanics needed to describe interest payment dates, day-count conventions, ranking, covenants or optional redemption terms. The disclosed note title establishes the 7.000% coupon and 2031 maturity year; it does not establish those other terms. No such terms are inferred here.

FACT: The company cautions that Item 1

The company cautions that Item 1.01 summarizes only the material provisions of the underwriting agreement and is qualified in its entirety by the agreement filed as Exhibit 1.1. The Form 8-K also states that it does not constitute an offer to sell or a solicitation to buy securities, and that sales cannot occur in a jurisdiction where they would be unlawful before registration or qualification under applicable securities laws.

CONTEXT: The next stated transaction milestone is the expected September 16 closi

The next stated transaction milestone is the expected September 16 closing. Confirmation that the offering actually closed would require subsequent evidence; this disclosure supplies an expectation subject to conditions. For now, the supported financial picture is a $300.0 million principal offering of 7.000% notes due 2031 with $296.5 million in disclosed prospective net proceeds. The filing does not establish a share-price reaction, a change in net asset value or any broader portfolio outcome.

Filing reference

Oaktree Specialty Lending Corporation disclosed the notes offering in Form 8-K AccNo 0001193125-26-389266 (Items 1.01 and 9.01; Underwriting Agreement dated September 9, 2026; Filing Date September 11, 2026).